Bottom line
HLHIX vs SCHLX: the short answer
HLHIX (Virtus KAR Health Sciences Fund) and SCHLX (DWS Health and Wellness Fund) are both mutual funds.
But SCHLX is far broader, holding 65 positions to 24 for HLHIX, so beyond the top names it adds exposure HLHIX doesn't have.
HLHIX is cheaper at 1.05% vs 1.06% — a difference of $1.00 a year per $10,000 invested.
Updated Nov 19, 2026
HLHIX vs SCHLX side by side
| HLHIX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Virtus | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.05% | 1.06% |
| Annual cost per $10k | $105 | $106 |
| 10-yr cost on $10k (prospectus) | $1,367 | $1,294 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +7.6% | — |
| 5-yr return (annualized) | +3.8% | — |
| 10-yr return (annualized) | +7.1% | — |
| Best quarter | +16.5% | — |
| Worst quarter | −11.8% | — |
| Net assets (fund) | $91.7M | $231.8M |
| Number of holdings | 24 | 65 |
| Portfolio turnover | 13% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of HLHIX's top 24 holdings also appear in SCHLX's top 25.
| Holding | HLHIX | SCHLX |
|---|---|---|
| Eli Lilly & Company | 14.84% | 13.85% |
| Abbvie Inc | 5.52% | 4.90% |
| Vertex Pharmaceuticals Inc | 5.32% | 2.45% |
| Merck & Company Inc | 5.06% | 4.85% |
| Unitedhealth Group Inc | 4.65% | 5.73% |
| Mckesson Corp | 4.57% | 2.05% |
| Intuitive Surgical Inc | 3.89% | 2.69% |
| Amgen Inc | 3.85% | 2.88% |
| Thermo Fisher Scientific Inc | 3.65% | 3.46% |
| Danaher Corp | 3.37% | 2.13% |
| Regeneron Pharmaceuticals Inc | 2.90% | 1.43% |
Source: SEC Form N-PORT
HLHIX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between HLHIX and SCHLX?
Which is cheaper, HLHIX or SCHLX?
Should I own both HLHIX and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.